Brief: Atossa Therapeutics Announces Support Of Final Rule From FDA Requiring Patient Notification Of Breast Density
10/09/2024 16:31
Sept 10 (Reuters) - Atossa Therapeutics Inc ATOS.O :
* ATOSSA THERAPEUTICS ANNOUNCES SUPPORT OF FINAL RULE FROM
FDA
REQUIRING PATIENT NOTIFICATION OF BREAST DENSITY, A CRITICAL
STEP IN ADDRESSING A KNOWN RISK FACTOR FOR BREAST CANCER
Source text for Eikon: ID:nGNXc3rFMm
Further company coverage: ATOS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Atossa Therapeutics
See all newsAtossa Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Atossa Therapeutics Q3 net loss narrows as clinical trial expenses decline
Brief: Atossa Therapeutics Executes Contingent Value Rights Agreement Providing Shareholders Participation In Potential Priority Review Voucher Value
US RESEARCH ROUNDUP-Amrize, Dexcom, Lennar
Atossa Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary